A Study Of A Mid-field MRI Scanner
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 26-004300
About this study
The purpose of this study is to evaluate the safety, feasibility, and imaging performance of an investigational 0.6T whole-body MRI scanner, derived from an FDA-approved 1.5T system, in human subjects. This study aims to generate preliminary data to assess the system’s potential clinical utility and to inform further technical development and optimization.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Age 18 years or older
Able and willing to provide written informed consent
Able to safely undergo MRI based on standard MRI safety screening
Willing to comply with study procedures, including completion of the research MRI scan
Exclusion Criteria:
Standard contraindications to clinical MRI (e.g., implanted devices that are contradicted for MRI, ferromagnetic foreign bodies)
Known or suspected pregnancy
Inability to tolerate MRI procedures (e.g., severe claustrophobia not manageable without sedation)
Significant medical or psychiatric condition that, in the opinion of the investigators, would make participation unsafe or interfere with study procedures
Inability to provide informed consent
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 04/21/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Yunhong Shu, Ph.D. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available